Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,424
archived clinical trials in
Cognitive Studies

Non-cancer Pain and Cognitive Impairment: A Disabling Relationship
Opioids Versus Extra Strength Acetaminophen for the Management of Moderate Persistent Non-cancer Pain
Status: Enrolling
Updated:  12/21/2010
University of Chicago Medical Center Outpatient Senior Health Center South Shore
mi
from
Chicago, IL
Non-cancer Pain and Cognitive Impairment: A Disabling Relationship
Opioids Versus Extra Strength Acetaminophen for the Management of Moderate Persistent Non-cancer Pain
Status: Enrolling
Updated: 12/21/2010
University of Chicago Medical Center Outpatient Senior Health Center South Shore
mi
from
Chicago, IL
Click here to add this to my saved trials
Effects of Strengthening Exercise on the Brain for Early Dementia and Normative Older Adults
Neuropsychological and Neuroimaging Effects of Strengthening Exercise for Early Dementia and Normative Older Adults
Status: Enrolling
Updated:  12/30/2010
Stratton VA Medical Center
mi
from
Albany, NY
Effects of Strengthening Exercise on the Brain for Early Dementia and Normative Older Adults
Neuropsychological and Neuroimaging Effects of Strengthening Exercise for Early Dementia and Normative Older Adults
Status: Enrolling
Updated: 12/30/2010
Stratton VA Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Building Complex Language
Building Complex Language: Effect of Treatment and Dosage
Status: Enrolling
Updated:  4/15/2011
Rush University Medical Center
mi
from
Chicago, IL
Building Complex Language
Building Complex Language: Effect of Treatment and Dosage
Status: Enrolling
Updated: 4/15/2011
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Building Complex Language
Building Complex Language: Effect of Treatment and Dosage
Status: Enrolling
Updated:  4/15/2011
Governors State University
mi
from
University Park, IL
Building Complex Language
Building Complex Language: Effect of Treatment and Dosage
Status: Enrolling
Updated: 4/15/2011
Governors State University
mi
from
University Park, IL
Click here to add this to my saved trials
Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment
An Open-Label, Two-Stage Study to Evaluate the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Plasma and CSF After a 10-Day Treatment Period in Subjects With Amnestic Mild Cognitive Impairment
Status: Enrolling
Updated:  6/11/2011
CEDRA Clinical Research, LLC
mi
from
San Antonio, TX
Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment
An Open-Label, Two-Stage Study to Evaluate the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Plasma and CSF After a 10-Day Treatment Period in Subjects With Amnestic Mild Cognitive Impairment
Status: Enrolling
Updated: 6/11/2011
CEDRA Clinical Research, LLC
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Rehabilitation Intervention for Amnestic Mild Cognitive Impairment
A Multicenter Rehabilitation Intervention for Amnestic Mild Cognitive Impairment
Status: Enrolling
Updated:  6/21/2011
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
A Rehabilitation Intervention for Amnestic Mild Cognitive Impairment
A Multicenter Rehabilitation Intervention for Amnestic Mild Cognitive Impairment
Status: Enrolling
Updated: 6/21/2011
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Rehabilitation Intervention for Amnestic Mild Cognitive Impairment
A Multicenter Rehabilitation Intervention for Amnestic Mild Cognitive Impairment
Status: Enrolling
Updated:  6/21/2011
Emory University
mi
from
Atlanta, GA
A Rehabilitation Intervention for Amnestic Mild Cognitive Impairment
A Multicenter Rehabilitation Intervention for Amnestic Mild Cognitive Impairment
Status: Enrolling
Updated: 6/21/2011
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Rehabilitation Intervention for Amnestic Mild Cognitive Impairment
A Multicenter Rehabilitation Intervention for Amnestic Mild Cognitive Impairment
Status: Enrolling
Updated:  6/21/2011
Mayo Clinic Rochester
mi
from
Rochester, MN
A Rehabilitation Intervention for Amnestic Mild Cognitive Impairment
A Multicenter Rehabilitation Intervention for Amnestic Mild Cognitive Impairment
Status: Enrolling
Updated: 6/21/2011
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment
Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment
Status: Enrolling
Updated:  8/3/2011
VA Connecticut Healthcare System
mi
from
West Haven, CT
Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment
Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment
Status: Enrolling
Updated: 8/3/2011
VA Connecticut Healthcare System
mi
from
West Haven, CT
Click here to add this to my saved trials
Behavioral and Affective Skills in Coping (BASIC) Open Trial
Behavioral and Affective Skills in Coping: Practice-Adapted Child Psychotherapy
Status: Enrolling
Updated:  11/9/2011
Judge Baker Children's Center
mi
from
Boston, MA
Behavioral and Affective Skills in Coping (BASIC) Open Trial
Behavioral and Affective Skills in Coping: Practice-Adapted Child Psychotherapy
Status: Enrolling
Updated: 11/9/2011
Judge Baker Children's Center
mi
from
Boston, MA
Click here to add this to my saved trials
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated:  12/12/2011
Cleveland Clinic Lou Ruvo Center for Brain Health
mi
from
Las Vegas, NV
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated: 12/12/2011
Cleveland Clinic Lou Ruvo Center for Brain Health
mi
from
Las Vegas, NV
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated:  12/12/2011
Cleveland Clinic Center for Brain Health - Mellen Center
mi
from
Cleveland, OH
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated: 12/12/2011
Cleveland Clinic Center for Brain Health - Mellen Center
mi
from
Cleveland, OH
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated:  12/12/2011
Cleveland Clinic Senior Care Assessment - Lakewood Hospital
mi
from
Lakewood, OH
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated: 12/12/2011
Cleveland Clinic Senior Care Assessment - Lakewood Hospital
mi
from
Lakewood, OH
Feeding Trial in Pediatric Patients
Enteral Formula Tolerance In Pediatric Patients With Developmental Disabilities
Status: Enrolling
Updated:  1/6/2012
The Children's Center
mi
from
Bethany, OK
Feeding Trial in Pediatric Patients
Enteral Formula Tolerance In Pediatric Patients With Developmental Disabilities
Status: Enrolling
Updated: 1/6/2012
The Children's Center
mi
from
Bethany, OK
Click here to add this to my saved trials
Minocycline in Patients With Alzheimer's Disease
MRI and MRS Diagnosis and Treatment Monitoring of Alzheimer's Disease With Novel Therapy
Status: Enrolling
Updated:  1/30/2012
Huntington Medical Research Institutes
mi
from
Pasadena, CA
Minocycline in Patients With Alzheimer's Disease
MRI and MRS Diagnosis and Treatment Monitoring of Alzheimer's Disease With Novel Therapy
Status: Enrolling
Updated: 1/30/2012
Huntington Medical Research Institutes
mi
from
Pasadena, CA
Click here to add this to my saved trials
Comparison of Two Psychosocial Therapies for Treating Children With Oppositional-Defiant Disorder
Mediators, Moderators, and Treatment Outcomes With ODD Youth
Status: Enrolling
Updated:  2/23/2012
Child Study Center
mi
from
Blacksburg, VA
Comparison of Two Psychosocial Therapies for Treating Children With Oppositional-Defiant Disorder
Mediators, Moderators, and Treatment Outcomes With ODD Youth
Status: Enrolling
Updated: 2/23/2012
Child Study Center
mi
from
Blacksburg, VA
Click here to add this to my saved trials
Exercise Effects on Cognition in School-Aged Children
ERPs to Academics: Exercise Effects on Cognition in School-Aged Children
Status: Enrolling
Updated:  3/7/2012
Univ of Illinois
mi
from
Chicago, IL
Exercise Effects on Cognition in School-Aged Children
ERPs to Academics: Exercise Effects on Cognition in School-Aged Children
Status: Enrolling
Updated: 3/7/2012
Univ of Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Mars Flavonol Exercise and Cognitive Function Study
Study of the Impact of a Flavonol Containing Food Product and Exercise on Cognitive Function and Brain Structure
Status: Enrolling
Updated:  3/8/2012
Columbia University Medical Center
mi
from
New York, NY
Mars Flavonol Exercise and Cognitive Function Study
Study of the Impact of a Flavonol Containing Food Product and Exercise on Cognitive Function and Brain Structure
Status: Enrolling
Updated: 3/8/2012
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders
Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders
Status: Enrolling
Updated:  3/29/2012
Rothman Center for Neuropsychiatry, University of South Florida
mi
from
St. Petersburg, FL
Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders
Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders
Status: Enrolling
Updated: 3/29/2012
Rothman Center for Neuropsychiatry, University of South Florida
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Cognitive Changes in Adult Cancer Survivors
Cognitive and Functional Changes With Chemotherapy in Adult Cancer
Status: Enrolling
Updated:  3/30/2012
Washington University School of Medicine
mi
from
Saint Louis, MO
Cognitive Changes in Adult Cancer Survivors
Cognitive and Functional Changes With Chemotherapy in Adult Cancer
Status: Enrolling
Updated: 3/30/2012
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Conversations as a Means to Delay the Onset of Alzheimer's Disease
Conversational Engagement as a Means to Delay Alzheimer's Disease Onset
Status: Enrolling
Updated:  4/4/2012
Oregon Health and Science University
mi
from
Portland, OR
Conversations as a Means to Delay the Onset of Alzheimer's Disease
Conversational Engagement as a Means to Delay Alzheimer's Disease Onset
Status: Enrolling
Updated: 4/4/2012
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Impact of Grape Consumption on Brain Metabolism and Cognitive Function
Examining the Impact of Grape Consumption on Brain Metabolism and Cognitive Function in Patients With Mild Cognitive Impairment
Status: Enrolling
Updated:  4/6/2012
UCLA Medical Center
mi
from
Los Angeles, CA
Impact of Grape Consumption on Brain Metabolism and Cognitive Function
Examining the Impact of Grape Consumption on Brain Metabolism and Cognitive Function in Patients With Mild Cognitive Impairment
Status: Enrolling
Updated: 4/6/2012
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Chemotherapy-Induced Cognitive Impairment
The Neurobiology of Chemotherapy-Induced Cognitive Impairment
Status: Enrolling
Updated:  4/17/2012
Washington University School of Medicine
mi
from
Saint Louis, MO
Chemotherapy-Induced Cognitive Impairment
The Neurobiology of Chemotherapy-Induced Cognitive Impairment
Status: Enrolling
Updated: 4/17/2012
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Childhood Anesthesia and Cognitive Function
Is Pediatric Anesthesia Associated With Long-term Hippocampal Dysfunction?
Status: Enrolling
Updated:  6/11/2012
University of Califoria, Davis
mi
from
Davis, CA
Childhood Anesthesia and Cognitive Function
Is Pediatric Anesthesia Associated With Long-term Hippocampal Dysfunction?
Status: Enrolling
Updated: 6/11/2012
University of Califoria, Davis
mi
from
Davis, CA
Click here to add this to my saved trials
Childhood Anesthesia and Cognitive Function
Is Pediatric Anesthesia Associated With Long-term Hippocampal Dysfunction?
Status: Enrolling
Updated:  6/11/2012
Univeristy of California, San Francisco
mi
from
San Francisco, CA
Childhood Anesthesia and Cognitive Function
Is Pediatric Anesthesia Associated With Long-term Hippocampal Dysfunction?
Status: Enrolling
Updated: 6/11/2012
Univeristy of California, San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive Impairment
Effect of Varenicline on a Laboratory Model of Tobacco Addiction and on Withdrawal-Induced Cognitive Impairment
Status: Enrolling
Updated:  6/28/2012
National Institute on Drug Abuse, Biomedical Research Center
mi
from
Baltimore, MD
Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive Impairment
Effect of Varenicline on a Laboratory Model of Tobacco Addiction and on Withdrawal-Induced Cognitive Impairment
Status: Enrolling
Updated: 6/28/2012
National Institute on Drug Abuse, Biomedical Research Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia
Cannabinoid Receptor Antagonist Treatment of Cognitive Dysfunction in Schizophrenia
Status: Enrolling
Updated:  7/17/2012
Yale University
mi
from
New Haven, CT
Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia
Cannabinoid Receptor Antagonist Treatment of Cognitive Dysfunction in Schizophrenia
Status: Enrolling
Updated: 7/17/2012
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder
Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder
Status: Enrolling
Updated:  7/19/2012
Mount Sinai School of Medicine
mi
from
New York, NY
Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder
Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder
Status: Enrolling
Updated: 7/19/2012
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days
Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days
Status: Enrolling
Updated:  7/30/2012
VA Puget Sound Health Care System
mi
from
Seattle, WA
Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days
Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days
Status: Enrolling
Updated: 7/30/2012
VA Puget Sound Health Care System
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction
A Feasibility Study of Donepezil in Female Breast Cancer Survivors With Self-Reported Cognitive Dysfunction Following Chemotherapy
Status: Enrolling
Updated:  8/24/2012
Wake Forest Cancer Center CCOP Research Base
mi
from
Winston Salem, NC
Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction
A Feasibility Study of Donepezil in Female Breast Cancer Survivors With Self-Reported Cognitive Dysfunction Following Chemotherapy
Status: Enrolling
Updated: 8/24/2012
Wake Forest Cancer Center CCOP Research Base
mi
from
Winston Salem, NC
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 001
mi
from
Dothan, AL
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 001
mi
from
Dothan, AL
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site
mi
from
Phoenix, AZ
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 055
mi
from
Tucson, AZ
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 055
mi
from
Tucson, AZ
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 077
mi
from
Little Rock, AR
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 077
mi
from
Little Rock, AR
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 054
mi
from
Glendale, CA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 054
mi
from
Glendale, CA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 109
mi
from
Imperial, CA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 109
mi
from
Imperial, CA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site #003
mi
from
Sherman Oaks, CA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site #003
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 17
mi
from
Los Angeles, CA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 17
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 021
mi
from
San Francisco, CA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 021
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 073
mi
from
Santa Ana, CA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 073
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative site 074
mi
from
Santa Ana, CA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative site 074
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site
mi
from
Oceanside, CA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 037
mi
from
Boulder, CO
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 037
mi
from
Boulder, CO
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 073
mi
from
Centennial, CO
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 073
mi
from
Centennial, CO
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 29
mi
from
Hartford, CT
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 29
mi
from
Hartford, CT
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 008
mi
from
Washington,
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 008
mi
from
Washington,
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 075
mi
from
Bradenton, FL
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 075
mi
from
Bradenton, FL
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 135
mi
from
Destin, FL
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 135
mi
from
Destin, FL
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 064
mi
from
Gainesville, FL
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 064
mi
from
Gainesville, FL
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 122
mi
from
Gulf Breeze, FL
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 122
mi
from
Gulf Breeze, FL
Click here to add this to my saved trials